Recruiting NA INTERVENTIONAL 2-arm
NCT07378683
A Clinical Prediction Model for Surgical Site Infection After Central Nervous System Tumor Surgery
A Prospective, Single-Center Clinical Validation Study: Machine Learning Model-Based Risk Stratification Intervention for Reducing Surgical Site Infection After Central Nervous System Tumor Surgery
Sponsor: Ming Yang
Updated 1 time since 2026 Last updated: Jan 22, 2026 Started: Jun 1, 2025 Primary completion: Oct 30, 2029 Completion: Oct 30, 2029
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
This NA trial investigates Central Nervous System Tumor and Surgical Site Infection (SSI) and is currently actively recruiting participants. Ming Yang leads this study, which shows 1 recorded version since 2025 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.
Status Flow
Change History
1 version recorded Recruiting — NA
[monthly]
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- Ming Yang
Data source: Cancer Institute and Hospital, Chinese Academy of Medical Sciences
For direct contact, visit the study record on ClinicalTrials.gov .